Transdifferentiation of Melanoma Cells by the Reprogramming Factors Attenuates Malignant Nature In?Vitro and In?Vivo
Transdifferentiation of Melanoma Cells by the Reprogramming Factors Attenuates Malignant Nature In?Vitro and In?Vivo
复制标题
重编程因子对黑色素瘤细胞的转分化可减弱体外和体内的恶性性质
DOI:
10.1016/j.jid.2018.06.179
复制
发表时间:
2019
影响因子:
6.5
通讯作者:
Sano Shigetoshi
中科院分区:
文献类型:
--
作者:
Takaishi Mikiro;Sano Shigetoshi
Prevention of metastasis is the ultimate aim to conquer cancers including malignant melanoma. It has been shown that malignancy of tumor cells is linked to acquired mesenchymal properties, namely epithelial-mesenchymal transition (EMT), not only in cancers of epithelial origin but also in malignant melanomas (Pearlman et al., 2017). Thus, suppression of the mesenchymal natures in malignant melanomas could be of therapeutic benefit. We have previously established reprogramming factor-introduced cancer cells (RICs) from squamous cell carcinoma (SCC) lines. The cells underwent mesenchymal-epithelial transition (MET) and attenuated their malignancy in vitro and in vivo (Takaishi et al., 2016). In this study, we investigated whether this was the case with melanoma cells.Previous reports showed that induced pluripotent stem cells were generated from mature melanocytes and melanoma cell lines by introduction of reprogramming genes (Bernhardt et al., 2017, Utikal et al., 2009). Here we introduced OCT3/4, SOX2, KLF4, c-MYC, and LIN28 into A2058 cells, a human melanoma line, as reported previously (Takaishi et al., 2016). Similar to SCC RICs, melanoma RICs showed the MET-like transdifferentiation with changes in cell morphology (Figure 1 a), but they were completely different from induced pluripotent stem cells. Reverse transcription PCR analysis showed down-regulation of melanocyte signature genes (MLANA, MITF, TYR, KIT, SOX9, and PAX3) in RICs compared with parental cells (Figure 1 b, see Supplementary Materials and Methods, and Supplementary Table S1 online). MITF protein level was reduced in the RICs (Figure 1 a and c, see Supplementary Materials and Methods, and Supplementary Table S2). MITF has significant roles not only for melanogenesis in melanocytes but also for growth and survival of melanoma cells (Wellbrock and Arozarena, 2015). It has been reported that overexpression of SOX2, one of the reprogramming factors, reduced the amount of MITF in MeWo cells (Cimadamore et al., 2012). The MITF gene is activated by several transcription factors including SOX10, PAX3, LEF1, CREB1, and others (Vachtenheim and Ondrusova, 2015). In this study, PAX3 was down-regulated in melanoma RICs (Figure 1 b). Therefore, the down-regulation of MITF in melanoma RICs could be due to increased SOX2 and decreased PAX3. Additionally, the mesenchymal signature molecules, including SNAI2 and ZEB2, were reduced in the melanoma RICs (Figure 1 b and c). These changes in the morphology and molecules were largely reproduced in RICs derived from mouse melanomas B16/BL6 (see Supplementary Figure S1 a–c online). The color of RIC cell pellet was pale, whereas the parental and mock control were black, indicating down-regulation of melanogenesis in the RICs (see Supplementary Figure S2 a online). Collectively, the data indicated that forced expression of the reprogramming factors into melanoma cells led to MET-like transdifferentiation.